1887
Rapid communication Open Access
Like 0

Abstract

On 3 April 2017, a wild poliovirus type 2 (WPV2) spill occurred in a Dutch vaccine manufacturing plant. Two fully vaccinated operators with risk of exposure were advised on stringent personal hygiene and were monitored for virus shedding. Poliovirus (WPV2-MEF1) was detected in the stool of one, 4 days after exposure, later also in sewage samples. The operator was isolated at home and followed up until shedding stopped 29 days after exposure. No further transmission was detected.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2017.22.21.30542
2017-05-25
2017-11-19
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2017.22.21.30542
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/22/21/eurosurv-22-21-1.html?itemId=/content/10.2807/1560-7917.ES.2017.22.21.30542&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use. Geneva: WHO; 2015. Available from: http://polioeradication.org/wp-content/uploads/2016/12/GAPIII_2014.pdf
  2. World Health Organization (WHO). International Health Regulations (2005) Third edition, 2016. Available from: http://apps.who.int/iris/bitstream/10665/246107/1/9789241580496-eng.pdf?ua=1
  3. World Health Organization (WHO). WHO Polio manual 2004: Polio laboratory manual. Geneva: WHO; Aug 2004. Available from: http://whqlibdoc.who.int/hq/2004/WHO_IVB_04.10.pdf
  4. Benschop KSM, van der Avoort HG, Jusic E, Vennema H, van Binnendijk R, Duizer E. Polio and measles down the drain: Environmental Enterovirus Surveillance in the Netherlands, 2005-2015. Appl Environ Microbiol. 2017.  PMID: 28432101 
  5. Ruijs WL, Hautvast JL, van der Velden K, de Vos S, Knippenberg H, Hulscher ME. Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study. BMC Public Health. 2011;11(1):102.  https://doi.org/10.1186/1471-2458-11-102  PMID: 21320348 
  6. Van Lier A, Oomen P, Giesbers H, Van Vliet H, Drijfhout I, Zonnenberg-Hoff IF, et al. Immunisation coverage National Immunisation Programme in the Netherlands; year of report 2016. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2016. Report No.: 2016-0064. Available from: http://www.rivm.nl/en/Documents_and_publications/Scientific/Reports/2016/juni/Immunisation_coverage_National_Immunisation_Programme_NIP_in_the_Netherlands_Year_of_report_2016
  7. National Institute for Public Health and the Environment (RIVM). LCI-richtlijn Virale hemorragische koorts filovirussen (ebola, marburg), Bijlage 9. Afvoeren van afval uit isolatiekamers van patiënten met virale hemorragische koorts. [LCI guideline Viral hemorrhagic fever filoviruses (Ebola, Marburg). Appendix 9. Disposal of waste from isolation chambers of patients with viral hemorrhagic fever]. Bilthoven: RIVM; Dutch. Available from: http://www.rivm.nl/dsresource?objectid=83bf7cbc-2e82-4554-8bd4-7a9eae49074c&type=org&disposition=inline
  8. Duizer E, Rutjes S, de Roda Husman AM, Schijven J. Risk assessment, risk management and risk-based monitoring following a reported accidental release of poliovirus in Belgium, September to November 2014. Euro Surveill. 2016;21(11):30169.  https://doi.org/10.2807/1560-7917.ES.2016.21.11.30169  PMID: 27020766 
  9. Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. J Infect Dis. 1991;163(1):1-6.  https://doi.org/10.1093/infdis/163.1.1  PMID: 1845806 
  10. Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, et al. Expert review on poliovirus immunity and transmission. Risk Anal. 2013;33(4):544-605.  https://doi.org/10.1111/j.1539-6924.2012.01864.x  PMID: 22804479 
  11. Pöyry T, Stenvik M, Hovi T. Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland. Appl Environ Microbiol. 1988;54(2):371-4. PMID: 2833160 
  12. Weil M, Shulman LM, Heiman S, Stauber T, Alfandari J, Weiss L, et al. Prolonged excretion of type-2 poliovirus from a primary immune deficient patient during the transition to a type-2 poliovirus-free world, Israel, 2016. Euro Surveill. 2016;21(47):30408.  https://doi.org/10.2807/1560-7917.ES.2016.21.47.30408  PMID: 27918258 
/content/10.2807/1560-7917.ES.2017.22.21.30542
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error